ArticleFrontiers in oncology2022

Immune-Related Biomarkers Improve Performance of Risk Prediction Models for Survival in Patients With Hepatocellular Carcinoma.

Haifeng Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.